JNJ lacks the growth to warrant a stock rally.
The big $4.7 billion talc verdict could open the floodgate on more lawsuits.
The net payout yield dip to only 4% is a negative signal.
The company has the cash flows to pay large settlements, but the balance sheet no longer supports aggressive buybacks on the dip.
READ FULL ARTICLE HERE